Live Quote · NASDAQPRLDHealthcare· Biotechnology

Prelude Therapeutics Incorporated

$3.23▼ 0.77%($-0.03)
MKT CAP $186.95MNEXT EARNINGS Mar 9, 2027
50%
Bullish
TickerSpark Score
62/100
▌ Mixed
67
Valuation
40
Profitability
95
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRLD research report →

Analyst Price Target
$8.00+147.7% vs. today

Range $8 – $8

Analyst RatingBuy
5 Buy1 Hold2 Sell

Price Chart

+101.87% · this period
$6.63$3.99$1.35Nov 20May 26Nov 20
52-Week Range35% of range
Low
$1.29
Current
$3.23
High
$6.83